We are live on
!
Find out more
FI
Fosun International Portfolio holdings
AUM
$399M
1-Year Est. Return
16.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.61%
1 Year Est. Return
-16.11%
3 Year Est. Return
+16.92%
5 Year Est. Return
-0.68%
10 Year Est. Return
+98.52%
AUM
$1.57B
AUM Growth
-$99.9M
(-6%)
Cap. Flow
-$270M
Cap. Flow
% of AUM
-17.18%
Top 10 Holdings %
Top 10 Hldgs %
52.85%
Holding
344
New
45
Increased
88
Reduced
69
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BZUN
Baozun
BZUN
|
+$17.1M |
| 2 |
MOMO
Hello Group
MOMO
|
+$5.31M |
| 3 |
HARP
Harpoon Therapeutics, Inc. Common Stock
HARP
|
+$4.25M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$4.13M |
| 5 |
Neurocrine Biosciences
NBIX
|
+$3.26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KANG
iKang Healthcare Group, Inc.
KANG
|
+$94.3M |
| 2 |
Vipshop
VIPS
|
+$47.3M |
| 3 |
DigitalBridge
DBRG
|
+$39.3M |
| 4 |
Brookdale Senior Living
BKD
|
+$37.8M |
| 5 |
Criteo
CRTO
|
+$15.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 37.62% |
| 2 | Financials | 6.46% |
| 3 | Consumer Discretionary | 4.13% |
| 4 | Industrials | 2.9% |
| 5 | Communication Services | 2.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Deutsche Bank
DB
$67.6B
| $6.47M | 0.41% |
793,000
| – | – |
|
|
CMTA
27
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $6.37M | 0.4% |
244,826
+10,300
| +4% | +$192K |
|
|
MOMO
28
Hello Group
MOMO
$869M
| $6.36M | 0.4% |
+166,223
| New | +$5.31M |
|
|
ALBO
29
DELISTED
Albireo Pharma Inc
ALBO
| $6.27M | 0.4% |
197,005
| – | – |
|
30
Brookfield
BN
$104B
| $5.91M | 0.38% |
355,947
-4,204
| -1% | -$65.5K |
|
31
Mastercard
MA
$497B
| $5.84M | 0.37% |
24,858
-382
| -2% | -$82.2K |
|
|
TGA
32
DELISTED
Transglobe Energy Corp
TGA
| $5.72M | 0.36% |
2,422,923
| – | – |
|
33
Brookfield Renewable
BEP
$9.7B
| $5.68M | 0.36% |
187,650
| – | – |
|
|
APLS
34
DELISTED
Apellis Pharmaceuticals
APLS
| $5.62M | 0.36% |
294,728
| – | – |
|
35
Alphabet (Google) Class A
GOOGL
$4.08T
| $5.55M | 0.35% |
94,700
-150,300
| -61% | -$8.49M |
|
36
AtriCure
ATRC
$2.01B
| $5.29M | 0.34% |
200,559
+3,100
| +2% | +$94.2K |
|
37
Kura Oncology
KURA
$826M
| $4.97M | 0.32% |
305,958
+101,724
| +50% | +$1.57M |
|
38
Amazon
AMZN
$2.48T
| $4.91M | 0.31% |
55,380
+17,740
| +47% | +$1.48M |
|
39
Ironwood Pharmaceuticals
IRWD
$626M
| $4.83M | 0.31% |
453,544
+38,389
| +9% | +$429K |
|
40
Alnylam Pharmaceuticals
ALNY
$38.5B
| $4.38M | 0.28% |
48,300
| – | – |
|
|
IMMU
41
DELISTED
Immunomedics Inc
IMMU
| $4.37M | 0.28% |
235,433
| – | – |
|
|
DERM
42
DELISTED
Dermira, Inc.
DERM
| $4.36M | 0.28% |
330,626
+16,713
| +5% | +$139K |
|
43
Visa
V
$697B
| $4.21M | 0.27% |
27,190
-6,000
| -18% | -$865K |
|
44
Booking.com
BKNG
$154B
| $4.13M | 0.26% |
59,750
+50
| +0.1% | +$3.57K |
|
|
OXFD
45
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $4.1M | 0.26% |
237,783
| – | – |
|
46
Alibaba
BABA
$276B
| $4.07M | 0.26% |
22,780
+9,545
| +72% | +$1.61M |
|
|
47
Bristol-Myers Squibb
BMY
$130B
| $3.97M | 0.25% |
+83,000
| New | +$4.13M |
|
48
Meta Platforms (Facebook)
META
$1.51T
| $3.95M | 0.25% |
23,887
-3,996
| -14% | -$635K |
|
49
Iovance Biotherapeutics
IOVA
$2.1B
| $3.92M | 0.25% |
413,154
+129,000
| +45% | +$1.25M |
|
50
BeyondSpring
BYSI
$48.9M
| $3.85M | 0.24% |
240,000
| – | – |
|
Similar funds
NC
T2I
BA
IAA
PNFS
THL
MHC
BWM
Fosun International's Q1 2019 Portfolio in Review
As of Q1 2019, Fosun International held 344 positions worth $1.57B, down 6% from $1.67B the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Fosun International withdrew a net $270M in Q1 2019, closing 37 positions and reducing 69 holdings. Its most notable exit was iKang Healthcare Group, Inc., an estimated $94.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 38% of assets, down from 39% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Fosun International opened a new position in Baozun worth $20.3M.
- Fosun International's largest Q1 2019 buy was Baozun: 488,992 shares worth $20.3M.
- Fosun International added most to Neurocrine Biosciences in Q1 2019, an estimated $3.26M increase.
- Fosun International's biggest Q1 2019 reduction was Vipshop, cutting an estimated $47.3M.
- Fosun International fully exited iKang Healthcare Group, Inc. in Q1 2019, selling an estimated $94.3M.
- Fosun International's ten largest holdings make up 53% of its $1.57B portfolio in Q1 2019.
- Fosun International opened 45 new positions and closed 37 in Q1 2019.
- Fosun International's portfolio value fell 6% quarter-over-quarter to $1.57B.
Based on Fosun International's 13F filing for Q1 2019, filed 10 May 2019.